// App-Quantinova.ai

P3.370 : Anti-cholinergic medications for bladder dysfunction worsen cognition in persons with Multiple Sclerosis (P3.370)

Researchers

Presenter

  • Sarah Anne Morrow

Principal Investigators

  • Heather Rosehart

  • Alp Sener

  • Blayne Welk

Medical Centers

  • London Health Sciences Center, London, ON, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Detrol

  • Oxybutynin

Outcome

  • N/A


Study Design

  • Prospective

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A